1. Home
  2. ICD-10 PCS Codes
  3. 3
  4. E
  5. 0
  6. 4 - Central Vein

Central Vein

  • 3E040 - Open
    • 3E0400
      • 3E04002 - Introduction Central Vein to High-dose Interleukin-2 with Antineoplastic, Open Approach
      • 3E04003 - Introduction Central Vein to Low-dose Interleukin-2 with Antineoplastic, Open Approach
      • 3E04005 - Introduction Central Vein to Other Antineoplastic with Antineoplastic, Open Approach
      • 3E0400M - Introduction Central Vein to Monoclonal Antibody with Antineoplastic, Open Approach
      • 3E0400P - Introduction Central Vein to Clofarabine with Antineoplastic, Open Approach
    • 3E0401
      • 3E04016 - Introduction Central Vein to Recombinant Human-activated Protein C with Thrombolytic, Open Approach
      • 3E04017 - Introduction Central Vein to Other Thrombolytic with Thrombolytic, Open Approach
    • 3E0402
      • 3E04028 - Introduction Central Vein to Oxazolidinones with Anti-infective, Open Approach
      • 3E04029 - Introduction Central Vein to Other Anti-infective with Anti-infective, Open Approach
    • 3E0403
      • 3E0403Z - Introduction Central Vein to No Qualifier with Anti-inflammatory, Open Approach
    • 3E0404
      • 3E0404Z - Introduction Central Vein to No Qualifier with Serum, Toxoid and Vaccine, Open Approach
    • 3E0406
      • 3E0406Z - Introduction Central Vein to No Qualifier with Nutritional Substance, Open Approach
    • 3E0407
      • 3E0407Z - Introduction Central Vein to No Qualifier with Electrolytic and Water Balance Substance, Open Approach
    • 3E040F
      • 3E040FZ - Introduction Central Vein to No Qualifier with Intracirculatory Anesthetic, Open Approach
    • 3E040G
      • 3E040GC - Introduction Central Vein to Other Substance with Other Therapeutic Substance, Open Approach
      • 3E040GN - Introduction Central Vein to Blood Brain Barrier Disruption with Other Therapeutic Substance, Open Approach
    • 3E040H
      • 3E040HZ - Introduction Central Vein to No Qualifier with Radioactive Substance, Open Approach
    • 3E040K
      • 3E040KZ - Introduction Central Vein to No Qualifier with Other Diagnostic Substance, Open Approach
    • 3E040N
      • 3E040NZ - Introduction Central Vein to No Qualifier with Analgesics, Hypnotics, Sedatives, Open Approach
    • 3E040P
      • 3E040PZ - Introduction Central Vein to No Qualifier with Platelet Inhibitor, Open Approach
    • 3E040R
      • 3E040RZ - Introduction Central Vein to No Qualifier with Antiarrhythmic, Open Approach
    • 3E040T
      • 3E040TZ - Introduction Central Vein to No Qualifier with Destructive Agent, Open Approach
    • 3E040V
      • 3E040VG - Introduction Central Vein to Insulin with Hormone, Open Approach
      • 3E040VH - Introduction Central Vein to Human B-type Natriuretic Peptide with Hormone, Open Approach
      • 3E040VJ - Introduction Central Vein to Other Hormone with Hormone, Open Approach
    • 3E040W
      • 3E040WK - Introduction Central Vein to Immunostimulator with Immunotherapeutic, Open Approach
      • 3E040WL - Introduction Central Vein to Immunosuppressive with Immunotherapeutic, Open Approach
    • 3E040X
      • 3E040XZ - Introduction Central Vein to No Qualifier with Vasopressor, Open Approach
  • 3E043 - Percutaneous
    • 3E0430
      • 3E04302 - Introduction Central Vein to High-dose Interleukin-2 with Antineoplastic, Percutaneous Approach
      • 3E04303 - Introduction Central Vein to Low-dose Interleukin-2 with Antineoplastic, Percutaneous Approach
      • 3E04305 - Introduction Central Vein to Other Antineoplastic with Antineoplastic, Percutaneous Approach
      • 3E0430M - Introduction Central Vein to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
      • 3E0430P - Introduction Central Vein to Clofarabine with Antineoplastic, Percutaneous Approach
    • 3E0431
      • 3E04316 - Introduction Central Vein to Recombinant Human-activated Protein C with Thrombolytic, Percutaneous Approach
      • 3E04317 - Introduction Central Vein to Other Thrombolytic with Thrombolytic, Percutaneous Approach
    • 3E0432
      • 3E04328 - Introduction Central Vein to Oxazolidinones with Anti-infective, Percutaneous Approach
      • 3E04329 - Introduction Central Vein to Other Anti-infective with Anti-infective, Percutaneous Approach
    • 3E0433
      • 3E0433Z - Introduction Central Vein to No Qualifier with Anti-inflammatory, Percutaneous Approach
    • 3E0434
      • 3E0434Z - Introduction Central Vein to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach
    • 3E0436
      • 3E0436Z - Introduction Central Vein to No Qualifier with Nutritional Substance, Percutaneous Approach
    • 3E0437
      • 3E0437Z - Introduction Central Vein to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach
    • 3E043F
      • 3E043FZ - Introduction Central Vein to No Qualifier with Intracirculatory Anesthetic, Percutaneous Approach
    • 3E043G
      • 3E043GC - Introduction Central Vein to Other Substance with Other Therapeutic Substance, Percutaneous Approach
      • 3E043GN - Introduction Central Vein to Blood Brain Barrier Disruption with Other Therapeutic Substance, Percutaneous Approach
      • 3E043GQ - Introduction Central Vein to Glucarpidase with Other Therapeutic Substance, Percutaneous Approach
      • 3E043GR - Introduction Central Vein to Other Therapeutic Monoclonal Antibody with Other Therapeutic Substance, Percutaneous Approach
    • 3E043H
      • 3E043HZ - Introduction Central Vein to No Qualifier with Radioactive Substance, Percutaneous Approach
    • 3E043K
      • 3E043KZ - Introduction Central Vein to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
    • 3E043N
      • 3E043NZ - Introduction Central Vein to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
    • 3E043P
      • 3E043PZ - Introduction Central Vein to No Qualifier with Platelet Inhibitor, Percutaneous Approach
    • 3E043R
      • 3E043RZ - Introduction Central Vein to No Qualifier with Antiarrhythmic, Percutaneous Approach
    • 3E043T
      • 3E043TZ - Introduction Central Vein to No Qualifier with Destructive Agent, Percutaneous Approach
    • 3E043V
      • 3E043VG - Introduction Central Vein to Insulin with Hormone, Percutaneous Approach
      • 3E043VH - Introduction Central Vein to Human B-type Natriuretic Peptide with Hormone, Percutaneous Approach
      • 3E043VJ - Introduction Central Vein to Other Hormone with Hormone, Percutaneous Approach
    • 3E043W
      • 3E043WK - Introduction Central Vein to Immunostimulator with Immunotherapeutic, Percutaneous Approach
      • 3E043WL - Introduction Central Vein to Immunosuppressive with Immunotherapeutic, Percutaneous Approach
    • 3E043X
      • 3E043XZ - Introduction Central Vein to No Qualifier with Vasopressor, Percutaneous Approach